50
Participants
Start Date
July 31, 2015
Primary Completion Date
February 8, 2019
Study Completion Date
February 8, 2019
XR-NTX+CM (Extended-Release Naltrexone plus Care Management)
The intervention arm will receive extended-release naltrexone (XR-NTX) 380mg (4 mL) to be administered as an intramuscular gluteal injection every 28 days up to 12 doses total. Expedited referral to alcohol-medical management. Care Management will include coordination of health care and social services for at least 12 months. Harm-reduction counseling and motivational interviewing to identify and work towards goals. The Standard care arm will receive an expedited alcohol-medical management referral.
Bellevue Hospital Center, New York
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NIH
NYU Langone Health
OTHER